Enabling Tomorrow's Breakthroughs Today
Our Services
We focus on indication selection and asset value maximisation
We assess your assets and goals to shape a focused indication strategy—leveraging advanced technology and expert networks to accelerate value, de-risk drug development, and expand impact.
For Life Sciences leaders and investors, we craft clear, strategic insight to unlock value, de-risk development, and accelerate smart growth ensuring every decision is grounded in data, opportunity, and impact.
We deliver real-world evidence-based indication prioritization that sharpens focus and streamlines decision-making across the portfolio.
We deliver high-impact strategies in weeks—validating known science, uncovering opportunities, and securing key milestones.
Biotech, Pharma, & Financial Sponsors
Guided by our Indication Strategy, we turn complexity into clarity. From asset sales to co-development, we align interests, manage risk, and deliver data-driven insights that empower unbiased, confident decisions.
True partnership, real alignment – We work as an extension of your team, ensuring every recommendation supports your goals.
Decisions backed by data and experts in the field – No guesswork. Actionable insights that drive smarter, faster, patentable outcomes.
Any deal size & type
Our Process
Turning real-world data into real-world impact
Discover how we create measurable success in Life Sciences programs.
01
Define the Right Data and Biological Anchors
We begin by sourcing high-quality real-world data (RWD) and identifying relevant patient cohorts. In parallel, we define key biological anchors based on the asset’s mechanism of action—guiding our exploration of disease relevance through phenotypic similarity, knowledge graphs, and omics data.
02
Discover and Score Indication Opportunities
Using AI-driven analytics, we generate and rank potential indications. Each is evaluated across scientific, clinical, and commercial dimensions—factoring in unmet need, feasibility, and strategic fit—validated through literature, expert input, and proprietary scoring models.
03
Deliver Data-Driven Recommendations
We develop detailed indication scorecards and a ranked opportunity list, tailored to your asset’s profile. These strategic outputs inform lifecycle planning, prioritization, and internal or external development options.
04
Execute on Strategy: Monetize or Advance
Beyond analysis, we support execution—providing buy- or sell-side advisory to help you monetize the asset or advance it through partnerships, co-development, or internal investment—maximizing strategic and financial return.